Free Trial

OncoSec Medical (ONCSQ) Competitors

ONCSQ vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

OncoSec Medical vs.

OncoSec Medical (NASDAQ:ONCSQ) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations, institutional ownership and community ranking.

OncoSec Medical and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
OncoSec MedicalN/AN/A
180 Life SciencesN/AN/A

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than OncoSec Medical. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for OncoSec Medical. 180 Life Sciences' average media sentiment score of 1.38 beat OncoSec Medical's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
OncoSec Medical Neutral
180 Life Sciences Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18MN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

180 Life Sciences beats OncoSec Medical on 2 of the 2 factors compared between the two stocks.

Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

MetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market CapN/A$7.05B$5.84B$9.15B
Dividend YieldN/A2.75%4.75%3.85%
P/E RatioN/A5.9726.4919.17
Price / SalesN/A268.58435.3770.93
Price / CashN/A65.6738.0134.83
Price / BookN/A6.707.644.62
Net Income-$34.18M$138.76M$3.19B$246.06M

OncoSec Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$0.00N/A0.0040
ATNFW
180 Life Sciences
N/A$0.01
+10.8%
N/A+51.5%$0.00N/A0.007News Coverage
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+7.6%
N/A-13.4%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.15
flat
N/A+138.5%$0.00$40,633.000.0040Gap Up
ALVOW
Alvotech
N/A$2.20
-8.3%
N/A-46.2%$0.00$391.87M0.004Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
flat
N/A-54.4%$0.00N/A0.004Gap Up
BFRIW
Biofrontera
N/A$0.06
-6.3%
N/A+254.1%$0.00$35.36M0.0070High Trading Volume
BTMDW
biote
N/A$0.50
flat
N/A-46.2%$0.00$193.06M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.12
+0.2%
N/A-92.9%$0.00N/A0.008Gap Down
CELUW
Celularity
N/A$0.07
flat
N/A+120.8%$0.00$48.20M0.00220

Related Companies and Tools


This page (NASDAQ:ONCSQ) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners